ST-001(SteroTherapeutics)

N/A

Report date: 2025/11/28 16:55:19
NME

Base Information

Drug NameST-001(SteroTherapeutics)
Drug Alias NameST-001(SteroTherapeutics)
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucose-6-phosphate 1-dehydrogenase inhibitors
TargetsGlucose-6-phosphate 1-dehydrogenase
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSteroTherapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesSteroTherapeutics LLC
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A